Literature DB >> 11453551

The involvement of p38 MAPK in transforming growth factor beta1-induced apoptosis in murine hepatocytes.

J H Liao1, J S Chen, M Q Chai, S Zhao, J G Song.   

Abstract

We reported in this manuscript that TGF-beta1 induces apoptosis in AML12 murine hepatocytes, which is associated with the activation of p38 MAPK signaling pathway. SB202190, a specific inhibitor of p38 MAPK, strongly inhibited the TGF-beta1-induced apoptosis and PAI-1 promoter activity. Treatment of cells with TGF-beta1 activates p38. Furthermore, over-expression of dominant negative mutant p38 also reduced the TGF-beta1-induced apoptosis. The data indicate that the activation of p38 is involved in TGF-beta1-mediated gene expression and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453551     DOI: 10.1038/sj.cr.7290072

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  18 in total

1.  TGF-β1 Suppresses IL-33-Induced Mast Cell Function.

Authors:  Victor S Ndaw; Daniel Abebayehu; Andrew J Spence; Patrick A Paez; E Motunrayo Kolawole; Marcela T Taruselli; Heather L Caslin; Alena P Chumanevich; Anuya Paranjape; Bianca Baker; Brian O Barnstein; Tamara T Haque; Kasalina N Kiwanuka; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2017-06-21       Impact factor: 5.422

2.  Differential phosphorylation of p38 induced by apoptotic and anti-apoptotic stimuli in murine hepatocytes.

Authors:  Li-Xia Guo; Hong Xie
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

3.  The RNA-binding protein human antigen R controls global changes in gene expression during Schwann cell development.

Authors:  Marta Iruarrizaga-Lejarreta; Marta Varela-Rey; Juan José Lozano; David Fernández-Ramos; Naiara Rodríguez-Ezpeleta; Nieves Embade; Shelly C Lu; Peter M van der Kraan; Esmeralda N Blaney Davidson; Myriam Gorospe; Rhona Mirsky; Kristján R Jessen; Ana María Aransay; José M Mato; María L Martínez-Chantar; Ashwin Woodhoo
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

Review 4.  Roles of Smad3 in TGF-beta signaling during carcinogenesis.

Authors:  Caroline Millet; Ying E Zhang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

5.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

Authors:  Motozo Yamashita; Karoly Fatyol; Chaoyang Jin; Xiangchun Wang; Zhenggang Liu; Ying E Zhang
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

Review 6.  Non-Smad pathways in TGF-beta signaling.

Authors:  Ying E Zhang
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

7.  LB-100 sensitizes hepatocellular carcinoma cells to the effects of sorafenib during hypoxia by activation of Smad3 phosphorylation.

Authors:  Qi-Han Fu; Qi Zhang; Jing-Ying Zhang; Xu Sun; Yu Lou; Guo-Gang Li; Zhi-Liang Chen; Xue-Li Bai; Ting-Bo Liang
Journal:  Tumour Biol       Date:  2015-12-14

8.  PPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis.

Authors:  Rong Zou; Gang Xu; Xiao-cheng Liu; Min Han; Jing-jing Jiang; Qian Huang; Yong He; Ying Yao
Journal:  Acta Pharmacol Sin       Date:  2009-12-28       Impact factor: 6.150

9.  Correlation between apoptosis and TGF-β1 expression in the mucosal epithelium of rat small intestine in a cold stress state.

Authors:  Yongjun Li; Dean Tian
Journal:  Exp Ther Med       Date:  2013-02-28       Impact factor: 2.447

10.  Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.

Authors:  Tomohiko Sakabe; Hiroyuki Tsuchiya; Keita Kanki; Junya Azumi; Kazue Gonda; Yusuke Mizuta; Daisaku Yamada; Hiroshi Wada; Kohei Shomori; Hiroaki Nagano; Goshi Shiota
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.